Related references
Note: Only part of the references are listed.alpha-Synuclein strains target distinct brain regions and cell types
Angus Lau et al.
NATURE NEUROSCIENCE (2020)
Chemical Chaperones as Novel Drugs for Parkinson's Disease
Jordi Pujols et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Polyphenols with Anti-Amyloid β Aggregation Show Potential Risk of Toxicity Via Pro-Oxidant Properties
Hatasu Kobayashi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Inhibition of α-Synuclein Aggregation and Mature Fibril Disassembling With a Minimalistic Compound, ZPDm
Samuel Pena-Diaz et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation
Valentina Oliveri
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions
Gergely Toth et al.
SCIENTIFIC REPORTS (2019)
Natural compound safranal driven inhibition and dis-aggregation of α-synuclein fibrils
Shreyada S. Save et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
ZPD-2, a Small Compound That Inhibits α-Synuclein Amyloid Aggregation and Its Seeded Polymerization
Samuel Pena-Diaz et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Protective effects of hydroxytyrosol against α-synuclein toxicity on PC12 cells and fibril formation
Ruth Hornedo-Ortega et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons
Jordi Pujols et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
α-Synuclein aggregation, seeding and inhibition by scyllo-inositol
Tarek Ibrahim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Protocatechuic Acid: Inhibition of Fibril Formation, Destabilization of Preformed Fibrils of Amyloid-β and α-Synuclein, and Neuroprotection
Ruth Hornedo-Ortega et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2016)
Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour
Giuliana Fusco et al.
NATURE COMMUNICATIONS (2014)
Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation
Diana F. Lazaro et al.
PLOS GENETICS (2014)
The Anti-Parkinsonian Drug Selegiline Delays the Nucleation Phase of α-Synuclein Aggregation Leading to the Formation of Nontoxic Species
Carolina A. Braga et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Tim Bartels et al.
NATURE (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity
Saviana Di Giovanni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Modulation of Alpha-Synuclein Aggregation by Dopamine Analogs
Diane Latawiec et al.
PLOS ONE (2010)
Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
Dong-Pyo Hong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro
K Ono et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease
J Li et al.
FASEB JOURNAL (2004)
Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease
PM Mattila et al.
ACTA NEUROPATHOLOGICA (2000)
Share Paper
